A detailed history of Ruggaard & Associates LLC transactions in Novartis Ag stock. As of the latest transaction made, Ruggaard & Associates LLC holds 7,286 shares of NVS stock, worth $787,033. This represents 0.31% of its overall portfolio holdings.

Number of Shares
7,286
Previous 7,421 1.82%
Holding current value
$787,033
Previous $854 Million 16.94%
% of portfolio
0.31%
Previous 0.37%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$96.78 - $117.18 $13,065 - $15,819
-135 Reduced 1.82%
7,286 $709 Million
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $7,747 - $8,824
73 Added 0.99%
7,421 $854 Million
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $24,160 - $28,023
-261 Reduced 3.43%
7,348 $782 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $9,241 - $10,521
97 Added 1.29%
7,609 $736 Million
Q4 2023

Feb 15, 2024

SELL
$92.27 - $101.54 $4,613 - $5,077
-50 Reduced 0.66%
7,512 $758 Million
Q3 2023

Nov 09, 2023

BUY
$94.73 - $105.13 $14,209 - $15,769
150 Added 2.02%
7,562 $770 Million
Q2 2023

Aug 10, 2023

BUY
$92.52 - $104.91 $8,326 - $9,441
90 Added 1.23%
7,412 $748 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $585,979 - $679,554
7,322 New
7,322 $674 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $232B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ruggaard & Associates LLC Portfolio

Follow Ruggaard & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruggaard & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ruggaard & Associates LLC with notifications on news.